Table 4 Metastatic risk of ALNs according to the novel scoring system, development set, and validation set.
Risk of Grade | Risk of Score | Metastasis risk (%) | ||
---|---|---|---|---|
Score system (%; [metastasis n/total n]) | Development set (%; [metastasis n/total n]) | Validation set (%; [metastasis n/total n]) | ||
1 | ≦ -1.5887 | 11.25 (27/240) | 10.00 (18/180) | 15.00 (9/60) |
2 | -1.5887 < score ≦ -0.06 | 34.40 (43/125) | 34.69 (34/98) | 33.33 (9/27) |
3 | -0.06 < score ≦ 1.5816 | 74.17 (89/120) | 76.67 (69/90) | 66.67 (20/30) |
4 | 1.5816 < score ≦ 2.4481 | 90.60 (106/117) | 90.48 (76/84) | 90.91 (30/33) |
5 | 2.4481 < score | 93.46 (100/107) | 94.94 (75/79) | 89.29 (25/28) |
Total | 51.48 (365/709) | 51.22 (272/531) | 52.25 (93/178) |